I’ve held a number of institutional, state and national leadership roles over the course of my career, I currently serve as director of the OSUCCC – James’ Stefanie Spielman Comprehensive Breast Center and as medical director of credentialing for the James Cancer Hospital and Solove Research Institute.
I have served on numerous national committees including, the Training Directions Committee for the Society of Surgical Oncology, the Joint Council for the Approval of Advanced Training in Head and Neck Surgery, and The American College of Surgeons Committee on Cancer.
I am principle investigator PI for the NSABP Clinical Trial Group at The Ohio State University.
I have authored or co-authored of more than 100 clinical studies and reviews published in scientific journals. My clinical research accomplishments have included studies published on such subjects as genetic counseling, sentinel lymph node mapping and biopsy, a procedure to determine if cancer cells have spread from the tumor to lymph nodes in the armpit.
I have earned many national accolades, including the “Best Doctors in America” listing, of which I am a 16-time recipient.
University of Virginia Hospitals
Ohio State University Wexner Medical Ctr
7/1/1976 - 6/30/1980
Specialties and conditions I treat
- Surgical Oncology
- Breast Cancer
- Parathyroid Cancers
- Hereditary Breast and Ovarian Cancer Syndrome
Locations where I practice
More about my work
American Board of Surgery
News about me
- Spielman Funds at James Cancer Hospital Top $10 Million
- Schottenstein Center To 'Go Pink' Today In Honor Of Breast Cancer Awareness Month
- The James Promotes Breast Cancer Awareness Month
- The James Kroger and City Hall Team Up To Turn Central Ohio Pink
- James Kenneths
- Advanced Radiation Oncology Wing Opens At JamesCare Comprehensive Breast Center
- Renowned Surgical Oncologist to Direct New Breast Center
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Farrar has reported no financial relationships with medical device, research and/or drug companies.